Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2012 (2012), Article ID 382518, 10 pages
http://dx.doi.org/10.1155/2012/382518
Research Article

Exenatide Pretreatment Improved Graft Function in Nonhuman Primate Islet Recipients Compared to Treatment after Transplant Only

1Division of Transplantation, Department of Surgery, 1st Floor, The Ohio State University, 395 West 12th Avenue, Columbus, OH 43210, USA
2Division of Endocrinology, Diabetes and Metabolism, 491 McCampbell Hall, 1581 Dodd Drive, Columbus, OH 43210, USA
3Office of Responsible Research Practices, University Laboratory Animal Resources, The Ohio State University, Columbus, 1960 Kenny Road, OH 43210, USA

Received 15 May 2012; Revised 16 July 2012; Accepted 8 August 2012

Academic Editor: Johan Olerud

Copyright © 2012 Jill L. Buss et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Collaborative Islet Transplant Registry, 7th Annual Report, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md, USA, 2011.
  2. Organ Procurement and Transplantation Network, Donors Recovered in the U.S. By Donor Type, United States Department of Health and Human Services, Washington, DC, USA, 2011.
  3. E. A. Ryan, B. W. Paty, P. A. Senior et al., “Five-year follow-up after clinical islet transplantation,” Diabetes, vol. 54, no. 7, pp. 2060–2069, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. J. Shapiro, J. R. T. Lakey, E. A. Ryan et al., “Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen,” The New England Journal of Medicine, vol. 343, no. 4, pp. 230–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Shalev, R. Ninnis, and U. Keller, “Effects of glucagon-like peptide 1 (7-36 amide) on glucose kinetics during somatostatin-induced suppression of insulin secretion in healthy men,” Hormone Research, vol. 49, no. 5, pp. 221–225, 1998. View at Publisher · View at Google Scholar
  6. J. Chen, F. M. Couto, A. H. Minn, and A. Shalev, “Exenatide inhibits β-cell apoptosis by decreasing thioredoxin-interacting protein,” Biochemical and Biophysical Research Communications, vol. 346, no. 3, pp. 1067–1074, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Xu, D. A. Stoffers, J. F. Habener, and S. Bonner-Weir, “Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats,” Diabetes, vol. 48, no. 12, pp. 2270–2276, 1999. View at Google Scholar · View at Scopus
  8. C. Tourrel, D. Bailbé, M. J. Meile, M. Kergoat, and B. Portha, “Glucagon-like peptide-1 and exendin-4 stimulate β-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age,” Diabetes, vol. 50, no. 7, pp. 1562–1570, 2001. View at Google Scholar · View at Scopus
  9. F. M. Couto, A. H. Minn, C. A. Pise-Masison et al., “Exenatide blocks JAK1-STAT1 in pancreatic beta cells,” Metabolism, vol. 56, no. 7, pp. 915–918, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. J. Kim, C. Nian, D. J. Doudet, and C. H. S. Mcintosh, “Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation,” Diabetes, vol. 58, no. 3, pp. 641–651, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. National Academy Press, Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington, DC, USA, 7th edition, 1996.
  12. A. Rajab, J. Buss, E. Diakoff, G. A. Hadley, K. Osei, and R. M. Ferguson, “Comparison of the portal vein and kidney subcapsule as sites for primate islet autotransplantation,” Cell Transplantation, vol. 17, no. 9, pp. 1015–1023, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Google Scholar · View at Scopus
  14. L. Li, W. El-Kholy, C. J. Rhodes, and P. L. Brubaker, “Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B,” Diabetologia, vol. 48, no. 7, pp. 1339–1349, 2005. View at Publisher · View at Google Scholar · View at Scopus